Question 1

What is the share price of Thyrocare Technologies Ltd today?

Accepted Answer

Thyrocare Technologies Ltd (THYROCARE) is trading at ₹463.15. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is THYROCARE’s P/E ratio versus the sector?

Accepted Answer

THYROCARE trades at a P/E of 50.8. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is THYROCARE’s dividend yield?

Accepted Answer

THYROCARE has a dividend yield of 1.75%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is THYROCARE’s 52-week high and low?

Accepted Answer

THYROCARE has traded between ₹342.55 and ₹662 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of Thyrocare Technologies Ltd?

Accepted Answer

Thyrocare Technologies Ltd has a market capitalisation of ₹8,493 crore.

Question 6

What is THYROCARE’s return on equity?

Accepted Answer

THYROCARE reports a return on equity of 26.8%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in Diagnostics & Research.

Question 7

Who are THYROCARE’s competitors?

Accepted Answer

The Peers block on this page lists other Diagnostics & Research companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is THYROCARE’s promoter holding?

Accepted Answer

Promoters hold 60.92% of THYROCARE. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include THYROCARE?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight THYROCARE carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is Thyrocare Technologies Ltd a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from THYROCARE’s own numbers. The judgement is yours.

Revenue	₹774 crore
Net profit	₹149 crore
Operating margin	33%
EPS	₹9.35

THYROCARE

THYROCARE

Fundamental Strength Index

Profitability

Growth

Segment Results

Working Capital & Efficiency

THYROCARE financial summary